Last reviewed: June 30, 2026
Last updated: June 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a glucagon-like peptide-1 receptor agonist, reduces hunger and slows stomach emptying to support sustainable weight loss. Unlike branded versions, the semaglutide dosing protocol remains consistent whether you're at a lower starting dose or a higher maintenance level—your price stays the same. Understanding how this medication works and what to expect during your treatment journey helps you make informed decisions about your weight loss strategy.
How Semaglutide Dosing Works for Weight Loss
Semaglutide treatment begins at a low dose to allow your body to adjust and reduce nausea and gastrointestinal side effects. Most patients start at 0.25 mg per week, a dose that activates GLP-1 receptors in your brain's appetite centers without overwhelming your system. The initial four-week phase establishes tolerance and baseline response, helping your healthcare provider determine if dose increases are necessary for optimal results.
Your dose typically increases every four weeks in 0.25 mg increments until you reach your target maintenance dose, usually between 1.0 mg and 2.4 mg weekly. This gradual escalation, called titration, maximizes weight loss effectiveness while your body adapts to the medication's effects on hunger signals and metabolism. Clinical trials show that patients who complete the full titration schedule experience better long-term weight loss outcomes than those who jump to higher doses too quickly.
Standard Semaglutide Dosage Schedule and Timeline
The typical semaglutide weight loss protocol spans 16 to 20 weeks during the titration phase, moving from 0.25 mg to a maintenance dose. Weeks 1–4 involve a 0.25 mg weekly injection, weeks 5–8 increase to 0.5 mg, weeks 9–12 reach 1.0 mg, weeks 13–16 advance to 1.7 mg, and weeks 17–20 may reach 2.4 mg depending on your response and tolerance. Some patients plateau at 1.7 mg with excellent results, while others benefit from continuing to 2.4 mg for additional weight reduction.
Once you achieve your target maintenance dose, you continue that same weekly injection indefinitely as long as you're experiencing benefits and tolerating the medication well. Your prescribing clinician monitors your progress at regular check-ins, adjusting your dose only if you develop side effects that warrant a temporary reduction or if weight loss plateaus despite compliance. Consistency with your weekly injection schedule is critical—missing doses or spacing them irregularly reduces the medication's appetite-suppressing effects.
Factors That Influence Your Personalized Semaglutide Dose
Your starting dose, titration pace, and maintenance target depend on several individual factors including your baseline weight, metabolic rate, kidney function, and tolerance for gastrointestinal effects. Patients with a history of pancreatitis or certain endocrine conditions may require modified dosing or additional monitoring. Your genetic makeup also influences how efficiently your body responds to GLP-1 signaling—PlexusDx's Precision Peptide Genetic Test identifies key variants in the GLP1R gene (rs6923761) and related pathways that predict your dose response potential.
Body composition, insulin resistance, and whether you have type 2 diabetes also shape your ideal dose trajectory. Patients with insulin resistance often tolerate higher doses better and experience more dramatic appetite suppression, while those with normal insulin sensitivity may reach their weight loss plateau at lower doses. Age, gender, and concurrent medications (especially those affecting stomach motility) require consideration during dose planning to balance efficacy with side effect management.
Why PlexusDx Pricing Stays Fixed Regardless of Your Dose
PlexusDx compounded semaglutide injections are priced at a flat $149 per month, meaning your cost remains identical whether you're starting at 0.25 mg or maintaining at 2.4 mg. This transparent pricing model removes the financial barrier to dose optimization—you never face higher copays or subscription fees as your clinician adjusts your dose upward during titration. Your medication comes from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality without the premium markups of branded alternatives.
The commitment to fixed pricing reflects PlexusDx's philosophy that cost should never limit your ability to reach your therapeutic dose. No membership fees, no insurance requirement, and HSA/FSA eligibility mean you control your healthcare spending. When you add PlexusDx's Precision Peptide Genetic Test ($99 after your first month), you gain actionable insights into your peptide-pathway genetics across 14 pathways and 150+ variants, helping your clinician refine your treatment plan with scientific precision.
What to Expect During Semaglutide Dose Escalation
During the first week at each new dose level, you may notice increased nausea, mild fatigue, or changes in appetite—these responses typically subside within a few days as your system acclimates. Weight loss usually accelerates after week two of a dose increase, with many patients losing 1 to 2 pounds weekly during the active titration phase. Staying well-hydrated, eating smaller protein-rich meals, and avoiding greasy foods significantly reduces gastrointestinal side effects and supports faster adaptation.
By week four at each dose, side effects generally diminish substantially while weight loss benefits stabilize and become noticeable. Your energy levels rebound, cravings decrease markedly, and you'll likely feel satisfied with smaller portion sizes—this is the medication working as intended. If you experience intolerable side effects, your clinician can hold your current dose for an extra week or two before advancing, or modify your dose upward more gradually than the standard protocol.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once per week for the first four weeks. This low introductory dose allows your body to adjust to the GLP-1 effects while minimizing nausea and other side effects. PlexusDx provides your starter dose through licensed 503A compounding pharmacies at $149 per month, with no additional cost as you advance through titration.
How long does it take to reach the full therapeutic dose?
Most patients complete titration in 16 to 20 weeks, advancing by 0.25 mg every four weeks until reaching a maintenance dose between 1.7 mg and 2.4 mg weekly. Some individuals achieve excellent results at lower doses and may not require escalation beyond 1.0 or 1.7 mg. Your clinician customizes your timeline based on your tolerance, weight loss response, and any side effects you experience.
Does PlexusDx charge more as my semaglutide dose increases?
No—PlexusDx compounded semaglutide remains a flat $149 per month regardless of your dose level or where you are in your titration schedule. Your dose may need to go up, but your price won't. This pricing structure applies across all three commitment tiers, ensuring transparent, predictable costs throughout your treatment.
What if I experience side effects at my current dose level?
Mild nausea and appetite changes are normal during titration and usually resolve within days. If side effects are intolerable, your clinician may extend your time at the current dose, reduce your dose temporarily, or adjust your dietary approach to fatty or spicy foods. Most patients successfully manage side effects without stopping the medication by using these strategies.
How does genetic testing help determine my ideal semaglutide dose?
PlexusDx's Precision Peptide Genetic Test identifies variants in your GLP1R gene (rs6923761) and related pathways that influence how strongly your body responds to semaglutide signaling. This peptide-pathway analysis maps 14 biological pathways and 150+ genetic insights, helping your clinician predict whether you'll respond robustly to lower doses or benefit from advancing to higher maintenance levels for maximum weight loss.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Journey: What Happens If I Forget to Take My Wegovy
What if I Miss an Ozempic Shot: A Guide to Staying on Track